Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Creating HIV-1 reverse transcriptase cytotoxic T lymphocyte target structures by HLA-A2 heavy chain modifications.

C S Dela Cruz1, R Tan, S L Rowland-Jones

  • 1Department of Immunology and Institute of Medical Science, University of Toronto, Medical Sciences Building, 1 King's College Circle, Ontario M5S 1A8, Canada.

International Immunology
|September 1, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Superior linear and comparable rotational protection of an air-filled helmet versus foam helmets.

Scientific reports·2025
Same author

Early antiviral use and supplemental oxygen decrease the risk of secondary bacterial infections: a multi-centre, nested, case-control study.

The Journal of hospital infection·2024
Same author

[A two-site combined prediction model based on HOXA9 DNA methylation for early screening of risks of meningioma progression].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University·2024
Same author

How Well Do Popular Bicycle Helmets Protect from Different Types of Head Injury?

Annals of biomedical engineering·2024
Same author

[Curcumol reverses temozolomide resistance in glioma cells by regulating the UTX/MGMT axis].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University·2023
Same author

[Protective effect and mechanism of AKAP1 on myocardial injury induced by highland hypobaric hypoxia].

Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases·2023

Developing effective HIV vaccines requires strong cytotoxic T lymphocyte (CTL) responses. New strategies enhance the presentation of HIV-1 epitopes, improving CTL recognition and potentially boosting vaccine efficacy against HIV.

Area of Science:

  • Immunology
  • Virology
  • Vaccine Development

Background:

  • Cytotoxic T lymphocyte (CTL) responses are crucial for controlling HIV-1 replication.
  • Strong, broadly cross-reactive CTL responses are a key goal for HIV vaccine development.
  • Effective CTL responses depend on high levels of MHC-viral peptide complexes on target cells.

Purpose of the Study:

  • To develop strategies for enhancing the presentation of HIV-1 epitope-specific CTL target structures.
  • To create effective CTL target structures using the human HLA-A2 molecule.
  • To investigate methods for inducing CTL responses against subdominant HIV-1 epitopes.

Main Methods:

  • Incorporating HIV-1 reverse transcriptase (RT) CTL epitope sequences into the HLA-A2 molecule.
  • Modifying HLA-A2 by incorporating epitopes into its signal sequence or tethering them to the heavy chain.

Related Experiment Videos

  • Assessing the recognition and lysis of modified HLA-A2 constructs by human HLA-A2-restricted RT-specific CD8(+) CTL.
  • Evaluating the stimulation of primary epitope-specific CTL generation in vitro by cells expressing these constructs.

    • Main Results:

    • Two strategies were successfully developed to enhance the presentation of HIV-1 CTL epitopes within the HLA-A2 molecule.
    • The modified HLA-A2 constructs served as effective CTL target structures, recognized and lysed by specific CTL.
    • Cells expressing these epitope-containing HLA-A2 constructs stimulated the in vitro generation of primary epitope-specific CTL.
    • These approaches provide novel ways to create effective CTL target structures for HIV-1.

    Conclusions:

    • Incorporating HIV-1 CTL epitopes into the signal sequence or tethering them to the HLA-A2 heavy chain are effective methods for creating CTL target structures.
    • These strategies can enhance the presentation of subdominant HIV-1 epitopes, leading to effective CTL recognition and lysis.
    • The developed strategies offer promising new options for designing plasmid DNA-based vaccines or immunotherapeutics aimed at inducing robust CTL responses against HIV-1.